jyy52w9i

Property	Value
?:abstract	Introduction: recent studies have reported the occurrence of thrombotic phenomena or coagulopathy in patients with COVID-19 There are divergent positions regarding the prevention, diagnosis, and treatment of these phenomena, and current clinical practice is based solely on deductions by extension from retrospective studies, case series, observational studies, and international guidelines developed prior to the pandemic Objective: to generate a group of recommendations on the prevention, diagnosis and management of thrombotic complications associated with COVID-19 Methods: a rapid guidance was carried out applying the GRADE Evidence to Decision (EtD) frameworks and an iterative participation system, with statistical and qualitative analysis Results: 31 clinical recommendations were generated focused on: a) Coagulation tests in symptomatic adults with suspected infection or confirmed SARS CoV-2 infection;b) Thromboprophylaxis in adults diagnosed with COVID-19 (Risk scales, thromboprophylaxis for outpatient, in-hospital management, and duration of thromboprophylaxis after discharge from hospitalization), c) Diagnosis and treatment of thrombotic complications, and d) Management of people with previous indication of anticoagulant agents Conclusions: recommendations of this consensus guide clinical decision-making regarding the prevention, diagnosis, and treatment of thrombotic phenomena in patients with COVID-19, and represent an agreement that will help decrease the dispersion in clinical practices according to the challenge imposed by the pandemic
is ?:annotates of	<https://research.tib.eu/covid-19/entity/jyy52w9i_hasAnnotation_C0040053>
?:creator	<https://research.tib.eu/covid-19/entity/Acevedo-Pe%C3%B1a%2C_J.%3B_Yomayusa-Gonz%C3%A1lez%2C_N.%3B_Cantor-Cruz%2C_F.%3B_Pinz%C3%B3n-Fl%C3%B3rez%2C_C.%3B_Barrero-Garz%C3%B3n%2C_L.%3B_De-La-Hoz-Siegler%2C_I.%3B_Low-Padilla%2C_E.%3B_Ram%C3%ADrez-Cer%C3%B3n%2C_C.%3B_Combariza-Vallejo%2C_F.%3B_Arias-Barrera%2C_C.%3B_Moreno-Cort%C3%A9s%2C_J.%3B_Rozo-Vanstrahlen%2C_J.%3B_Correa-P%C3%A9rez%2C_L.%3B_Rojas-Gambasica%2C_J.%3B_Gonz%C3%A1lez-Gonz%C3%A1lez%2C_C.%3B_La-Rotta-Caballero%2C_E.%3B_Ru%C3%ADz-Talero%2C_P.%3B_Contreras-P%C3%A1ez%2C_R.%3B_Lineros-Monta%C3%B1ez%2C_A.%3B_Ordo%C3%B1ez-Cardales%2C_J.%3B_Escobar-Olaya%2C_M.%3B_Izaguirre-%C3%81vila%2C_R.%3B_Campos-Guerra%2C_J.%3B_Accini-Mendoza%2C_J.%3B_Pizarro-G%C3%B3mez%2C_C.%3B_Pati%C3%B1o-P%C3%A9rez%2C_A.%3B_Flores-Rodr%C3%ADguez%2C_J.%3B_Valencia-Moreno%2C_A.%3B_Londo%C3%B1o-Villegas%2C_A.%3B_Saavedra-Rodr%C3%ADguez%2C_A.%3B_Madera-Rojas%2C_A.%3B_Caballero-Arteagam%2C_A.%3B_D%C3%ADaz-Campos%2C_A.%3B_Correa-Rivera%2C_F.%3B_Mantilla-Reinaud%2C_A.%3B_Becerra-Torres%2C_%C3%81_Pe%C3%B1a-Castellanos_%C3%81_Reina-Soler_A.%3B_Escobar-Suarez%2C_B.%3B_Pati%C3%B1o-Escobar%2C_B.%3B_Rodr%C3%ADguez-Cort%C3%A9s%2C_C.%3B_Rebolledo-Maldonado%2C_C.%3B_Ocampo-Botero%2C_C.%3B_Rivera-Ordo%C3%B1ez%2C_C.%3B_Saavedra-Trujillo%2C_C.%3B_Figueroa-Restrepo%2C_C.%3B_Agudelo-L%C3%B3pez%2C_C.%3B_Jaramillo-Villegas%2C_C.%3B_Villaquir%C3%A1n-Torres%2C_C.%3B_Rodr%C3%ADguez-Ariza%2C_D.%3B_Rinc%C3%B3n-Valenzuela%2C_D.%3B_Lemus-Rojas%2C_M.%3B_Pinto-Pinz%C3%B3n%2C_D.%3B_Garz%C3%B3n-D%C3%ADaz%2C_D.%3B_Cubillos-Apolinar%2C_D.%3B_Beltr%C3%A1n-Linares%2C_E.%3B_Kondo-Rodr%C3%ADguez%2C_E.%3B_Yama-Mosquera%2C_E.%3B_Polania-Fierro%2C_E.%3B_Real-Urbina%2C_E.%3B_Rosas-Romero%2C_A.%3B_Mendoza-Beltr%C3%A1n%2C_F.%3B_Guevara-Pulido%2C_F.%3B_Celia-M%C3%A1rquez%2C_G.%3B_Ramos-Ramos%2C_G.%3B_Prada-Mart%C3%ADnez%2C_G.%3B_Le%C3%B57e3165a5402625f7cc3d06bf05660cf>
?:journal	Revista_Colombiana_de_Cardiologia
?:license	unk
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:source	WHO
?:title	Colombian consensus for the prevention, diagnosis and treatment of thrombotic conditions in adults with COVID-19: applying GRADE Evidence to Decision (EtD) Frameworks
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:who_covidence_id	#917411
?:year	2020

Property

Value

?:abstract

Introduction: recent studies have reported the occurrence of thrombotic phenomena or coagulopathy in patients with COVID-19 There are divergent positions regarding the prevention, diagnosis, and treatment of these phenomena, and current clinical practice is based solely on deductions by extension from retrospective studies, case series, observational studies, and international guidelines developed prior to the pandemic Objective: to generate a group of recommendations on the prevention, diagnosis and management of thrombotic complications associated with COVID-19 Methods: a rapid guidance was carried out applying the GRADE Evidence to Decision (EtD) frameworks and an iterative participation system, with statistical and qualitative analysis Results: 31 clinical recommendations were generated focused on: a) Coagulation tests in symptomatic adults with suspected infection or confirmed SARS CoV-2 infection;b) Thromboprophylaxis in adults diagnosed with COVID-19 (Risk scales, thromboprophylaxis for outpatient, in-hospital management, and duration of thromboprophylaxis after discharge from hospitalization), c) Diagnosis and treatment of thrombotic complications, and d) Management of people with previous indication of anticoagulant agents Conclusions: recommendations of this consensus guide clinical decision-making regarding the prevention, diagnosis, and treatment of thrombotic phenomena in patients with COVID-19, and represent an agreement that will help decrease the dispersion in clinical practices according to the challenge imposed by the pandemic

is ?:annotates of

<https://research.tib.eu/covid-19/entity/jyy52w9i_hasAnnotation_C0040053>

?:creator

<https://research.tib.eu/covid-19/entity/Acevedo-Pe%C3%B1a%2C_J.%3B_Yomayusa-Gonz%C3%A1lez%2C_N.%3B_Cantor-Cruz%2C_F.%3B_Pinz%C3%B3n-Fl%C3%B3rez%2C_C.%3B_Barrero-Garz%C3%B3n%2C_L.%3B_De-La-Hoz-Siegler%2C_I.%3B_Low-Padilla%2C_E.%3B_Ram%C3%ADrez-Cer%C3%B3n%2C_C.%3B_Combariza-Vallejo%2C_F.%3B_Arias-Barrera%2C_C.%3B_Moreno-Cort%C3%A9s%2C_J.%3B_Rozo-Vanstrahlen%2C_J.%3B_Correa-P%C3%A9rez%2C_L.%3B_Rojas-Gambasica%2C_J.%3B_Gonz%C3%A1lez-Gonz%C3%A1lez%2C_C.%3B_La-Rotta-Caballero%2C_E.%3B_Ru%C3%ADz-Talero%2C_P.%3B_Contreras-P%C3%A1ez%2C_R.%3B_Lineros-Monta%C3%B1ez%2C_A.%3B_Ordo%C3%B1ez-Cardales%2C_J.%3B_Escobar-Olaya%2C_M.%3B_Izaguirre-%C3%81vila%2C_R.%3B_Campos-Guerra%2C_J.%3B_Accini-Mendoza%2C_J.%3B_Pizarro-G%C3%B3mez%2C_C.%3B_Pati%C3%B1o-P%C3%A9rez%2C_A.%3B_Flores-Rodr%C3%ADguez%2C_J.%3B_Valencia-Moreno%2C_A.%3B_Londo%C3%B1o-Villegas%2C_A.%3B_Saavedra-Rodr%C3%ADguez%2C_A.%3B_Madera-Rojas%2C_A.%3B_Caballero-Arteagam%2C_A.%3B_D%C3%ADaz-Campos%2C_A.%3B_Correa-Rivera%2C_F.%3B_Mantilla-Reinaud%2C_A.%3B_Becerra-Torres%2C_%C3%81_Pe%C3%B1a-Castellanos_%C3%81_Reina-Soler_A.%3B_Escobar-Suarez%2C_B.%3B_Pati%C3%B1o-Escobar%2C_B.%3B_Rodr%C3%ADguez-Cort%C3%A9s%2C_C.%3B_Rebolledo-Maldonado%2C_C.%3B_Ocampo-Botero%2C_C.%3B_Rivera-Ordo%C3%B1ez%2C_C.%3B_Saavedra-Trujillo%2C_C.%3B_Figueroa-Restrepo%2C_C.%3B_Agudelo-L%C3%B3pez%2C_C.%3B_Jaramillo-Villegas%2C_C.%3B_Villaquir%C3%A1n-Torres%2C_C.%3B_Rodr%C3%ADguez-Ariza%2C_D.%3B_Rinc%C3%B3n-Valenzuela%2C_D.%3B_Lemus-Rojas%2C_M.%3B_Pinto-Pinz%C3%B3n%2C_D.%3B_Garz%C3%B3n-D%C3%ADaz%2C_D.%3B_Cubillos-Apolinar%2C_D.%3B_Beltr%C3%A1n-Linares%2C_E.%3B_Kondo-Rodr%C3%ADguez%2C_E.%3B_Yama-Mosquera%2C_E.%3B_Polania-Fierro%2C_E.%3B_Real-Urbina%2C_E.%3B_Rosas-Romero%2C_A.%3B_Mendoza-Beltr%C3%A1n%2C_F.%3B_Guevara-Pulido%2C_F.%3B_Celia-M%C3%A1rquez%2C_G.%3B_Ramos-Ramos%2C_G.%3B_Prada-Mart%C3%ADnez%2C_G.%3B_Le%C3%B57e3165a5402625f7cc3d06bf05660cf>

?:journal

Revista_Colombiana_de_Cardiologia

?:license

?:publication_isRelatedTo_Disease

<https://research.tib.eu/covid-19/entity/COVID-19>

?:source

?:title

Colombian consensus for the prevention, diagnosis and treatment of thrombotic conditions in adults with COVID-19: applying GRADE Evidence to Decision (EtD) Frameworks

?:type